Further, analyses of clinical tumor gene expression data sets demonstrated a negative correlation between vascular normalization markers and mTORC1 target gene signatures and a positive correlation between GM-CSF levels and molecular markers of T cell and DC activation. The gene discussed is CSF2; the disease is neoplasm.